New York OKs Quest's Fragile X Syndrome Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Quest Diagnostics today said that New York has given the go-ahead for the company's test for Fragile X Syndrome, making it now available in all 50 states.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.